Skip to content
GLP-1 Scorecard
Menu
Graded #269

June Health

June Health is a direct-to-consumer telehealth storefront selling compounded GLP-1 medication for weight loss, alongside peptide, hormone, and hair-loss programs, all delivered online with no office visits.

Visit June HealthWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$179/mo (starting dose, compounded)
Tirzepatide
$179/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh June Health against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because June Health dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value60/100
Dose & formulation75/100
Clinical oversight59/100
Labs & monitoring51/100
Fulfillment74/100
Contract terms55/100

Strengths

  • Offers both injectable and oral compounded semaglutide and tirzepatide
  • Semaglutide starts at $179/mo (injectable) or $187/mo (tablets) — tirzepatide from $179/mo (injectable)
  • Full per-dose price list published on-site with no signup required to view it
  • Provider consult ('licensed clinician evaluation') is bundled into the displayed price
  • Free discreet shipping advertised with 2-3 day delivery

Where it loses points

  • No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
  • No LegitScript seal or other pharmacy-verification badge found anywhere on the site
  • Legal entity, prescribing medical group, and compounding pharmacy partner are not named
  • Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
  • Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use

Bottom line — Grade C

Best for: Shoppers comparing published per-dose compounded GLP-1 pricing on a brand-new, unverified telehealth site.

Ranked #269 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest June Health — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect June Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on June Health's site. Not medical advice; see our disclosure.

← Back to the scorecard